Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05613010 · ClinicalTrials.gov registry record · NA
Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
A NA study of Adherence, Medication and Adherence, Patient, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT05613010: Recruiting NA study of Adherence, Medication and Adherence, Patient, sponsored by Johns Hopkins University.
NCT05613010 is a NA study of Adherence, Medication and Adherence, Patient that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 65 participants, below the 832-participant average among 13 other Adherence, Medication trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05613010, a NA study of Adherence, Medication and Adherence, Patient, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
Can the investigators create an effective way to improve adherence to immunosuppressant medication and reduce rejection, graft loss, and death in adolescents and young adults who have undergone kidney or liver transplantation? The investigators' mobile technology intervention uses real-time electronic pillbox-assessed dose timing and text message prompts to address antirejection medication nonadherence when nonadherence is detected.
Primary Outcome
Participants will use an electronic pillbox to assess daily immunosuppressant adherence (tacrolimus or sirolimus), defined as a binary variable: dose taken or not.
Conditions Studied
Interventions
- BEHAVIORAL mHealth Messaging Intervention Group
Study Locations (1)
Maryland
- Johns Hopkins - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2024-03-19 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What NCT05613010 shows while recruiting
NCT05613010 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 832-participant average among 13 other Adherence, Medication trials with a reported enrollment target (92% lower).
The record links to 5 conditions, with Adherence, Medication appearing as the primary indexed condition, and to 1 intervention - of which mHealth Messaging Intervention Group is the first listed.
NCT05613010 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05613010 about?
NCT05613010 is a clinical study titled "Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant". Can the investigators create an effective way to improve adherence to immunosuppressant medication and reduce rejection, graft loss, and death in adolescents and young adults who have undergone kidney or liver transplantation? The investigators' mobile technology intervention uses real-time electron...
What is the current status of trial NCT05613010?
This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2024-03-19. Estimated completion is 2026-11-30.
What conditions does trial NCT05613010 study?
This clinical trial studies the following conditions: Adherence, Medication, Adherence, Patient, Transplant;Failure,Kidney, Adherence, Treatment, Transplant; Failure, Liver.
What interventions are being tested in trial NCT05613010?
The interventions under investigation include: mHealth Messaging Intervention Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05613010?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05613010 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adherence, Medication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05613010's enrollment target sits among peer trials
65 8th of 13 higher than 6 of 13 other Adherence, Medication trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adherence, Medication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Health Program for Rural Hypertension
RECRUITING · NA
-
BMT4me: Post-HSCT Medication Adherence mHealth App
RECRUITING · NA
-
Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications
COMPLETED · NA
-
Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users
COMPLETED · NA
-
The Impact of Patch Rx Technologies on Adherence to Vitamin and Trikafta Therapies in Patients With Cystic Fibrosis
COMPLETED · NA
-
Adherence and Outcomes in Functional Constipation With a Constipation Action Plan
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI